Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
ALX
$228.75
$-3.01
Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metropolitan area.
Next Earnings
2026-01-11
Beta
0.789
Average Volume
61482
Market Cap
1168292588
Last Dividend
18
CIK
0000003499
ISIN
US0147521092
CUSIP
014752109
CEO
Steven Roth
Sector
Real Estate
Industry
REIT - Retail
Full Time Employees
90
IPO Date
1973-02-21
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference | SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced its participation in the 44th Annual J.P. | GlobeNewsWire | 2026-01-08 11:00:00 |
| ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004 | - First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician's choice of chemotherapy in HER2-positive metastatic breast cancer; interim analysis anticipated Q3 2026 – | GlobeNewsWire | 2026-01-08 08:30:00 |
| Best Income Stocks to Buy for December 31st | ALX, KFRC and BHP made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 31, 2025. | Zacks Investment Research | 2025-12-31 03:46:05 |
| Alexander's Completes Restructuring of Retail Loan at 731 Lexington Avenue | PARAMUS, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has restructured the $300 million mortgage loan on the retail condominium of 731 Lexington Avenue in Manhattan. Under the terms of the restructuring, the existing loan was split into a $132.5 million senior “A-Note” accruing current interest at 7.00% per annum and a $167.5 million junior “C-Note” accruing interest at 4.55% per annum, with a new maturity date of December 23, 2035. | GlobeNewsWire | 2025-12-29 08:44:00 |
| Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened | Alexander's, Inc. (NYSE: ALX - Get Free Report) saw unusually-high trading volume on Friday. Approximately 44,573 shares were traded during trading, an increase of 1% from the previous session's volume of 44,283 shares.The stock last traded at $217.3350 and had previously closed at $218.16. Analysts Set New Price Targets A number of brokerages have recently | Defense World | 2025-12-28 02:55:06 |
| Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened | Alexander's, Inc. (NYSE: ALX - Get Free Report) shares saw an uptick in trading volume on Friday. 54,369 shares traded hands during trading, an increase of 25% from the previous session's volume of 43,607 shares.The stock last traded at $217.48 and had previously closed at $218.56. Analysts Set New Price Targets ALX has been the | Defense World | 2025-12-21 03:32:50 |
| Alexander's: Fed Tailwinds Drive FFO Growth | Alexander's, Inc. is a commercial REIT managing five properties in New York, with Bloomberg accounting for 60% of revenues. ALX's Q3 2025 results show FFO growth of 2.5%, principally driven by lower funding costs, which more than offset a drop in net operating income. Looking ahead to Q4 2025 and 2026, I see ALX's net operating income returning to growth thanks to recent occupancy gains. | Seeking Alpha | 2025-12-19 11:37:24 |
| Alexander’s (NYSE:ALX) Shares Cross Below 200 Day Moving Average – Here’s Why | Shares of Alexander's, Inc. (NYSE: ALX - Get Free Report) passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $229.44 and traded as low as $214.80. Alexander's shares last traded at $215.8270, with a volume of 80,019 shares traded. Wall Street Analyst Weigh In A number | Defense World | 2025-12-16 05:30:58 |
| Alexander's Completes $175 Million Refinancing of Rego Park II | PARAMUS, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has completed a $175 million refinancing of its 615,000 square foot Rego Park II shopping center located in Queens, New York. The interest-only loan is at SOFR plus 2.00%, currently 5.82%, and matures in December 2030. | GlobeNewsWire | 2025-12-09 08:59:00 |
| Dividends Up To 20% Wall Street Says You Should Sell | We contrarians follow Wall Street analysts because we like to fade their opinions! | Forbes | 2025-11-22 09:35:07 |
| ALX Oncology to Present at Upcoming Investor Conferences | SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York. | GlobeNewsWire | 2025-11-18 11:00:00 |
| Best Income Stocks to Buy for Nov. 13 | ALX, PFBC and WFRD made it to the Zacks Rank #1 (Strong Buy) income stocks list on Nov. 13, 2025. | Zacks Investment Research | 2025-11-13 04:56:07 |
| ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update | SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update. | GlobeNewsWire | 2025-11-07 08:15:00 |
| Is Alexander's (ALX) Outperforming Other Finance Stocks This Year? | Here is how Alexander's (ALX) and Affiliated Managers Group (AMG) have performed compared to their sector so far this year. | Zacks Investment Research | 2025-11-06 10:40:16 |
| ALX Oncology (ALXO) Expected to Announce Earnings on Friday | ALX Oncology (NASDAQ: ALXO - Get Free Report) is expected to be posting its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect ALX Oncology to post earnings of ($0.37) per share for the quarter. Interested persons may review the information on the company's upcoming Q3 2025 earningreport for the latest details | Defense World | 2025-11-06 01:02:44 |
| Alexander's Announces Third Quarter Financial Results | PARAMUS, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- ALEXANDER'S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2025 today and reported: | GlobeNewsWire | 2025-11-03 09:17:00 |
| ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting | SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced plans to report its third quarter 2025 financial results and provide a business update on Friday, November 7th, 2025, before market open. | GlobeNewsWire | 2025-10-30 08:30:00 |
| Alexander's Breaks Above 8% Yield Territory | In trading on Wednesday, shares of Alexander's were yielding above the 8% mark based on its quarterly dividend (annualized to $18), with the stock changing hands as low as $224.25 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return. | Forbes | 2025-10-29 15:30:03 |
| Alexander's Declares Quarterly $4.50 Dividend on Common Shares | PARAMUS, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on November 28, 2025 to stockholders of record on November 10, 2025. | GlobeNewsWire | 2025-10-29 13:37:00 |
| ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference | -Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors | GlobeNewsWire | 2025-10-23 12:30:00 |
| Alexander's Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call | PARAMUS, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended September 30, 2025 with the U.S. Securities and Exchange Commission and issue its third quarter earnings release on Monday, November 3, 2025, before the New York Stock Exchange opens. | GlobeNewsWire | 2025-10-21 13:23:00 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 8-K | 2025-12-29 | 2025-12-29 | View Filing |
| 8-K | 2025-12-09 | 2025-12-09 | View Filing |
| 10-Q | 2025-11-03 | 2025-11-03 | View Filing |
| 10-Q | 2025-08-04 | 2025-08-04 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 4 | 2025-05-23 | 2025-05-23 | View Filing |
| 8-K | 2025-05-22 | 2025-05-22 | View Filing |
| 10-Q | 2025-05-05 | 2025-05-05 | View Filing |
| ARS | 2025-04-08 | 2025-04-08 | View Filing |
| DEFA14A | 2025-04-08 | 2025-04-08 | View Filing |
| DEF 14A | 2025-04-08 | 2025-04-08 | View Filing |
| 10-K | 2025-02-10 | 2025-02-10 | View Filing |
| 8-K | 2024-12-30 | 2024-12-30 | View Filing |
| 10-Q | 2024-11-04 | 2024-11-04 | View Filing |
| 8-K | 2024-09-30 | 2024-09-30 | View Filing |
| 10-Q | 2024-08-05 | 2024-08-05 | View Filing |
| 8-K | 2024-06-12 | 2024-06-11 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 4 | 2024-05-24 | 2024-05-24 | View Filing |
| 8-K | 2024-05-23 | 2024-05-23 | View Filing |
| 10-Q | 2024-05-06 | 2024-05-06 | View Filing |
| ARS | 2024-04-09 | 2024-04-09 | View Filing |
| DEFA14A | 2024-04-09 | 2024-04-09 | View Filing |
| DEF 14A | 2024-04-09 | 2024-04-09 | View Filing |
| SC 13G/A | 2024-02-13 | 2024-02-13 | View Filing |
| 10-K | 2024-02-12 | 2024-02-12 | View Filing |
| SC 13G/A | 2024-02-06 | 2024-02-06 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|---|---|---|---|---|---|
| Larry Williams PercentR Strategy | 8.05% | 1 | 166 | 0.02 | 0.05 | 11.66 |
| Williams PercentR Strategy | 8.04% | 1 | 282 | 0.01 | 0.05 | 11.65 |
| Bollinger Bands Strategy | 6.89% | 1 | 92 | 0.01 | 0.06 | 10.5 |
| xxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | x | xxxx | xxxx |
| xxx | xxxxxxx% | x | xxx | x | xxxx | xxxx |
| xxxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | x | xxx | xxxxx | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | x | xxxx |
| xxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxxx% | xxxx | xxx | xxxxx | x | xxx |
| xxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxxx | x | xxxx |
| xxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | x | xxxx |
| xxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | x |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxxx |
| xxxx | xxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxx | xxxxx |